CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −376 | $571.41 | $215K | 41,153 |
| 2026-05-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −195 | $573.00 | $112K | 40,958 |
| 2026-05-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −245 | $574.08 | $141K | 40,713 |
| 2026-05-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $577.26 | $115K | 40,513 |
| 2026-05-20 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 192,910 | ||
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −51 | $561.52 | $29K | 49,962 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −109 | $562.31 | $61K | 49,853 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,237 | $565.54 | $700K | 48,616 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,140 | $566.34 | $1.2M | 46,476 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,149 | $567.38 | $652K | 45,327 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,640 | $568.46 | $932K | 43,687 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,393 | $569.42 | $793K | 42,294 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,099 | $570.35 | $627K | 41,195 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −562 | $571.24 | $321K | 40,633 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $572.36 | $69K | 40,513 |
| 2026-05-19 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 202,410 | ||
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +2,500 | $135.42 | $339K | 21,376 |
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +7,500 | $117.76 | $883K | 28,876 |
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −200 | $562.91 | $113K | 28,676 |
Page 100 of 121 · 2,404 trades